There is a newer version of the record available.

Published October 26, 2020 | Version v1
Journal article

Penile cancer: a Brazilian consensus statement for low- and middle-income countries

  • 1. Latin American Cooperative Oncology Group (Brazil)
  • 2. Hospital Israelita Albert Einstein. Department of Oncology (Brazil)
  • 3. Centro Paulista de Oncologia-Oncoclínicas. Department of Oncology (Brazil)
  • 4. Instituto Abathon (Brazil)
  • 5. Hospital Israelita Albert Einstein. Department of Radiotherapy (Brazil)
  • 6. Hospital Ophir Loyola. Department of Urology (Brazil)
  • 7. Hospital São Domingos. Department of Oncology (Brazil)
  • 8. Hospital Universitário da Universidade Federal do Maranhão. Department of Oncology (Brazil)
  • 9. Hospital Haroldo Juaçaba. Department of Radiotherapy (Brazil)
  • 10. Hospital Sírio-Libanês. Department of Oncology (Brazil)
  • 11. Hospital Haroldo Juaçaba. Department of Oncology (Brazil)
  • 12. Medical Research Laboratory of the Discipline of Urology, Faculdade de Medicina da USP (Brazil)
  • 13. Santa Casa de Misericórdia de Maceió. Department of Urology (Brazil)
  • 14. Hospital do Câncer Aldenora Bello. Department of Oncology (Brazil)

Description

Purpose

: Penile cancer is highly prevalent in low- and middle-income countries, with significant morbidity and mortality rates. The first Brazilian consensus provides support to improve penile cancer patients' outcomes, based on expert's opinion and evidence from medical literature.

Methods

: Fifty-one Brazilian experts (clinical oncologists, radiation oncologists, urologists, and pathologists) assembled and voted 104 multiple-choice questions, confronted the results with the literature, and ranked the levels of evidence.

Results

: Healthcare professionals need to deliver more effective communication about the risk factors for penile cancer. Staging and follow-up of patients include physical examination, computed tomography, and magnetic resonance imaging. Close monitoring is crucial, because most recurrences occur in the first 2–5 years. Lymph-node involvement is the most important predictive factor for survival, and management depends on the location (inguinal or pelvic) and the number of lymph nodes involved. Conservative treatment may be helpful in selected patients without compromising oncological outcomes; however, surgery yields the lowest rate of local recurrence.

Conclusion

: This consensus provides an essential decision-making orientation regarding this challenging disease.

Additional details

Identifiers

Publishing Information

Journal Title
Journal of Cancer Research and Clinical Oncology
Journal Volume
146
Journal Issue
12
Journal Page Range
p. 3281-3296
ISSN
0171-5216
CODEN
JCROD7

Optional Information

Copyright
Copyright (c) 2020 © The Author(s) 2020